Associated equity: Basilea Pharmaceutica
Basilea Pharmaceutica is focused on treating infectious diseases. Its marketed products are Cresemba (an antifungal) and Zevtera (an anti-MRSA broad-spectrum antibiotic). The company plans to file for US approval for Zevtera.
Basilea Pharmaceutica — 6 videos in collection
In this video, CEO David Veitch introduces the company, its assets and sets out the key near-term milestones.
Get access to the very latest content matched to your personal investment style.